139 related articles for article (PubMed ID: 36283723)
1. Off-label use in adult palliative care - more common than expected. A retrospective chart review.
Hagemann V; Bausewein C; Remi C
Eur J Hosp Pharm; 2022 Nov; 29(6):329-335. PubMed ID: 36283723
[TBL] [Abstract][Full Text] [Related]
2. Off-label prescribing in palliative care - a cross-sectional national survey of palliative medicine doctors.
To TH; Agar M; Shelby-James T; Abernethy AP; Doogue M; Rowett D; Ko D; Currow DC
Palliat Med; 2013 Apr; 27(4):320-8. PubMed ID: 23128901
[TBL] [Abstract][Full Text] [Related]
3. Off-Label and Unlicensed Drugs in Pediatric Palliative Care: A Prospective Observational Study.
García-López I; Cuervas-Mons Vendrell M; Martín Romero I; de Noriega I; Benedí González J; Martino-Alba R
J Pain Symptom Manage; 2020 Nov; 60(5):923-932. PubMed ID: 32569831
[TBL] [Abstract][Full Text] [Related]
4. Drug use beyond the licence in palliative care: A systematic review and narrative synthesis.
Hagemann V; Bausewein C; Remi C
Palliat Med; 2019 Jun; 33(6):650-662. PubMed ID: 31017533
[TBL] [Abstract][Full Text] [Related]
5. Off-label drugs in palliative care: a Group Delphi treatment recommendation process.
Remi C; Weingärtner K; Hagemann V; Bausewein C; Hodiamont F
BMJ Support Palliat Care; 2021 Jun; 11(2):180-187. PubMed ID: 32398226
[TBL] [Abstract][Full Text] [Related]
6. Administration of label and off-label drugs by the subcutaneous route in palliative care: an observational cohort study.
Jensen JJ; Sjøgren P
BMJ Support Palliat Care; 2022 Dec; 12(e6):e723-e729. PubMed ID: 32887729
[TBL] [Abstract][Full Text] [Related]
7. Drug use evaluation of tamoxifen focusing on off-label use in a managed care population in Israel.
Kahan NR; Waitman DA; Blackman S; Vardy DA
J Manag Care Pharm; 2010 Jun; 16(5):355-9. PubMed ID: 20518588
[TBL] [Abstract][Full Text] [Related]
8. [Off-label use in palliative medicine].
Rémi C; Gerlach C
Schmerz; 2021 Feb; 35(1):61-73. PubMed ID: 33443680
[TBL] [Abstract][Full Text] [Related]
9. Off-label drug use in oncology: a systematic review of literature.
Saiyed MM; Ong PS; Chew L
J Clin Pharm Ther; 2017 Jun; 42(3):251-258. PubMed ID: 28164359
[TBL] [Abstract][Full Text] [Related]
10. Off-Label Medication Use in the Inpatient Palliative Care Unit.
Kwon JH; Kim MJ; Bruera S; Park M; Bruera E; Hui D
J Pain Symptom Manage; 2017 Jul; 54(1):46-54. PubMed ID: 28479415
[TBL] [Abstract][Full Text] [Related]
11. Off-label drugs use in pediatric palliative care.
De Zen L; Marchetti F; Barbi E; Benini F
Ital J Pediatr; 2018 Nov; 44(1):144. PubMed ID: 30486873
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Guideline Evidence for Off-label Medication Use in the Intensive Care Unit.
Shoulders BR; Smithburger PL; Tchen S; Buckley M; Lat I; Kane-Gill SL
Ann Pharmacother; 2017 Jul; 51(7):529-542. PubMed ID: 28622741
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous Drugs and Off-label Use in Hospice and Palliative Care: A Scoping Review.
Wernli U; Dürr F; Jean-Petit-Matile S; Kobleder A; Meyer-Massetti C
J Pain Symptom Manage; 2022 Nov; 64(5):e250-e259. PubMed ID: 35870656
[TBL] [Abstract][Full Text] [Related]
14. Off-label use of drugs in pain medicine and palliative care: an algorithm for the assessment of its safe and legal prescription.
Verhagen CC; Niezink AG; Engels YY; Hekster YY; Doornebal JJ; Vissers KC
Pain Pract; 2008; 8(3):157-63. PubMed ID: 18373512
[TBL] [Abstract][Full Text] [Related]
15. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
[TBL] [Abstract][Full Text] [Related]
16. Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.
Wong J; Motulsky A; Abrahamowicz M; Eguale T; Buckeridge DL; Tamblyn R
BMJ; 2017 Feb; 356():j603. PubMed ID: 28228380
[No Abstract] [Full Text] [Related]
17. Drug Information Needs of Health Care Professionals in Palliative Care: A Retrospective Evaluation of a Palliative Care Drug Information Service.
Hermann A; Bausewein C; Rémi C
J Pain Symptom Manage; 2021 Sep; 62(3):e28-e37. PubMed ID: 33652097
[TBL] [Abstract][Full Text] [Related]
18. Randomized Study of Providing Evidence Context to Mitigate Physician Misinterpretation Arising From Off-Label Drug Promotion.
Schwartz LM; Woloshin S; Lu Z; Ross KM; Tessema FA; Peter D; Kesselheim AS
Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e006073. PubMed ID: 31707825
[TBL] [Abstract][Full Text] [Related]
19. Association of Off-label Drug Use and Adverse Drug Events in an Adult Population.
Eguale T; Buckeridge DL; Verma A; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
JAMA Intern Med; 2016 Jan; 176(1):55-63. PubMed ID: 26523731
[TBL] [Abstract][Full Text] [Related]
20. Off-label drug prescriptions in French general practice: a cross-sectional study.
Drogou F; Netboute A; Giai J; Dode X; Darmon D; Kassai B; Letrilliart L
BMJ Open; 2019 Apr; 9(4):e026076. PubMed ID: 30967407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
